Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Letaplimab (Anti-CD47) For research use only.
Not for use in humans.

Letaplimab (Anti-CD47)

Synonyms: IBI-188

Letaplimab (Anti-CD47) is a human immunoglobulin G4 (IgG4) monoclonal antibody targeting leukocyte surface antigen CD47 with potential immunostimulating and antineoplastic activities. MW : 142.88 KD.

Letaplimab (Anti-CD47)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Letaplimab (Anti-CD47) is a human immunoglobulin G4 (IgG4) monoclonal antibody targeting leukocyte surface antigen CD47 with potential immunostimulating and antineoplastic activities. MW : 142.88 KD.

Product Details

CAS No. 2283356-07-8
Molecular Weight 142.88
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Letaplimab (Anti-CD47) | Letaplimab (Anti-CD47) supplier | purchase Letaplimab (Anti-CD47) | Letaplimab (Anti-CD47) cost | Letaplimab (Anti-CD47) manufacturer | order Letaplimab (Anti-CD47) | Letaplimab (Anti-CD47) distributor